Choline preparations in the treatment of asthenic states: modernity and perspectives (A Clinical Case Presentation)
In this article, we want to present the reader with an interesting clinical case from authors’ practice, which, in our opinion, clearly demonstrates the efficacy and safety of using Gliatilin (choline alfoscerate) as a part of combination therapy in a 19-year-old man with so-called «long COVID syndr...
Saved in:
| Main Authors: | Yu. V. Bykov, R. A. Bekker |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
Federal State Budget Scientific Institution National Medical Research Center for Psychiatry and Neurology n.a. V.M. Bekhterev Ministry of Health of the Russian Federation
2022-12-01
|
| Series: | Обозрение психиатрии и медицинской психологии имени В.М. Бехтерева |
| Subjects: | |
| Online Access: | https://www.bekhterevreview.com/jour/article/view/753 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Experience in using ceretone (choline alfoscerate) in brain concussion
by: N. G. Voropay, et al.
Published: (2010-12-01) -
Trends and determinants of choline alfoscerate use in newly diagnosed Alzheimer's disease patients in Korea
by: Yeon Hee Kim, et al.
Published: (2024-10-01) -
Choline Alphoscerat (Gliatilin) in the pathogenetic therapy of Alzheimer’s disease
by: D. V. Zaharov, et al.
Published: (2019-02-01) -
The Post-COVID-19 cognitive impairment. A modern view of the problem, pathogenesis and treatment
by: D. V. Zakharov, et al.
Published: (2021-12-01) -
CLINICAL EXPERIENCE WITH METABOLIC THERAPY FOR BRAIN ISCHEMIA
by: M. Kh. Shurdumova, et al.
Published: (2014-07-01)